The Centers for Medicare and Medicaid (CMS) announced Friday it will not be finalizing a rule proposed by the Biden ...

It seems like everyone and their sister is taking a GLP-1 (“glucagon-like peptide-1 receptor agonists,” if you’re feeling nasty), or is at least thinking about it. These meds—which include Ozempic, ...

Doug Long, BA, MBA, vice president of Industry Relations at IQVIA, shares what's happening in the growing GLP-1 and biosimilars space. Long was a presenter at the annual AMCP 2025 meeting in Houston, ...

GLP-1 agonists may lead to increased nausea and vomiting in the early postoperative period after total hip arthroplasty, ...

Conducted in partnership with Morning Consult, the study found that GLP-1 users are increasingly prioritizing high-protein, ...

Men in general have been playing golf for a longer time – in those old boy networks we still haven’t tapped into.” It may seem far-fetched, but that is put forward as a reason for underinvestment in ...

Originally developed to treat Type 2 diabetes, glucagon-like peptide 1 (GLP-1s) are now being studied to explore their ...

The recent uptick and rise in popularity of GLP-1 drugs for addressing weight loss and obesity has led to an increase in U.S. litigation ...

While most guidelines require 6 months of behavioral interventions before prescribing weight-loss drugs, new research shows ...

If we cut or limit funding for curiosity-driven research, we risk shutting down the pipeline of future innovation,” writes ...